RATIONALE: Drug addiction represents a pathological usurpation of neural processes involved in learning and memory. Retrieval of drug-related memories can result in drug craving and relapse. Recently, the insula was identified as part of the neuronal circuit responsible for the processing of drug memory; however, its precise role remains unclear. OBJECTIVE: To investigate the involvement of insular muscarinic acetylcholine receptors (mAChRs) in the processing of drug memory. METHOD: The morphine-induced conditioned place preference (CPP) was used to assess drug memory. All rats were first trained with morphine to establish the CPP. Sub-groups of these rats were used for contextual cue-induced CPP reinstatement. Other sub-groups of rats underwent extinction of the CPP, and 5 m/kg morphine was used for priming-induced CPP reinstatement. Microinjection of mAChR antagonists or agonists into the insula was performed prior to the CPP tests in order to evaluate their effect on CPP expression. RESULTS: Insular microinjections of the nonselective mAChR antagonist, scopolamine, and the M₁ antagonist, pirenzepine, significantly inhibited CPP expression in both contextual cue- and priming-induced CPP reinstatement; the M₁ agonist, MCN-A-343, and the M₄ antagonist, tropicamide, enhanced CPP expression. The M₄ agonist, LY2033298, inhibited CPP expression. The M₂ antagonist, methoctramine, and M₃ antagonist, 4-DAMP, had no effect on CPP expression. CONCLUSION: Our results demonstrate that insular mAChRs play a role in the processing of drug memory. M₁ and M₄ mAChRs work paradoxically; M₁ activation and M₄ inhibition attenuate the expression of drug memory, while M₁ inhibition and M₄ activation augment the expression of drug memory.
RATIONALE: Drug addiction represents a pathological usurpation of neural processes involved in learning and memory. Retrieval of drug-related memories can result in drug craving and relapse. Recently, the insula was identified as part of the neuronal circuit responsible for the processing of drug memory; however, its precise role remains unclear. OBJECTIVE: To investigate the involvement of insular muscarinic acetylcholine receptors (mAChRs) in the processing of drug memory. METHOD: The morphine-induced conditioned place preference (CPP) was used to assess drug memory. All rats were first trained with morphine to establish the CPP. Sub-groups of these rats were used for contextual cue-induced CPP reinstatement. Other sub-groups of rats underwent extinction of the CPP, and 5 m/kg morphine was used for priming-induced CPP reinstatement. Microinjection of mAChR antagonists or agonists into the insula was performed prior to the CPP tests in order to evaluate their effect on CPP expression. RESULTS: Insular microinjections of the nonselective mAChR antagonist, scopolamine, and the M₁ antagonist, pirenzepine, significantly inhibited CPP expression in both contextual cue- and priming-induced CPP reinstatement; the M₁ agonist, MCN-A-343, and the M₄ antagonist, tropicamide, enhanced CPP expression. The M₄ agonist, LY2033298, inhibited CPP expression. The M₂ antagonist, methoctramine, and M₃ antagonist, 4-DAMP, had no effect on CPP expression. CONCLUSION: Our results demonstrate that insular mAChRs play a role in the processing of drug memory. M₁ and M₄ mAChRs work paradoxically; M₁ activation and M₄ inhibition attenuate the expression of drug memory, while M₁ inhibition and M₄ activation augment the expression of drug memory.
Authors: Ranier Gutiérrez; Carlos J Rodriguez-Ortiz; Vanesa De La Cruz; Luis Núñez-Jaramillo; Federico Bermudez-Rattoni Journal: Neurobiol Learn Mem Date: 2003-11 Impact factor: 2.877
Authors: Rita Z Goldstein; A D Bud Craig; Antoine Bechara; Hugh Garavan; Anna Rose Childress; Martin P Paulus; Nora D Volkow Journal: Trends Cogn Sci Date: 2009-08-27 Impact factor: 20.229
Authors: Anel A Jaramillo; Verda E Agan; Viren H Makhijani; Stephen Pedroza; Zoe A McElligott; Joyce Besheer Journal: Addict Biol Date: 2017-09-27 Impact factor: 4.280
Authors: A Belin-Rauscent; M-L Daniel; M Puaud; B Jupp; S Sawiak; D Howett; C McKenzie; D Caprioli; M Besson; T W Robbins; B J Everitt; J W Dalley; D Belin Journal: Mol Psychiatry Date: 2015-09-15 Impact factor: 15.992